206 related articles for article (PubMed ID: 10393851)
1. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.
Pan G; Vickers SM; Pickens A; Phillips JO; Ying W; Thompson JA; Siegal GP; McDonald JM
Am J Pathol; 1999 Jul; 155(1):193-203. PubMed ID: 10393851
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
Pawar P; Ma L; Byon CH; Liu H; Ahn EY; Jhala N; Arnoletti JP; McDonald JM; Chen Y
Clin Cancer Res; 2009 Feb; 15(4):1288-96. PubMed ID: 19228732
[TBL] [Abstract][Full Text] [Related]
3. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma.
Ahn EY; Pan G; Vickers SM; McDonald JM
Int J Cancer; 2002 Aug; 100(4):445-51. PubMed ID: 12115528
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).
Vickers SM; Jhala NC; Ahn EY; McDonald JM; Pan G; Bland KI
Ann Surg; 2002 Jun; 235(6):872-8. PubMed ID: 12035045
[TBL] [Abstract][Full Text] [Related]
5. Fas expression prevents cholangiocarcinoma tumor growth.
Pickens A; Pan G; McDonald JM; Vickers SM
J Gastrointest Surg; 1999; 3(4):374-81; discussion 382. PubMed ID: 10482689
[TBL] [Abstract][Full Text] [Related]
6. Fas binding to calmodulin regulates apoptosis in osteoclasts.
Wu X; Ahn EY; McKenna MA; Yeo H; McDonald JM
J Biol Chem; 2005 Aug; 280(33):29964-70. PubMed ID: 15965236
[TBL] [Abstract][Full Text] [Related]
7. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
Chen Y; Pawar P; Pan G; Ma L; Liu H; McDonald JM
J Cell Biochem; 2008 Feb; 103(3):788-99. PubMed ID: 17654480
[TBL] [Abstract][Full Text] [Related]
9. Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors.
Frankfurt OS; Sugarbaker EV; Robb JA; Villa L
Cancer Lett; 1995 Nov; 97(2):149-54. PubMed ID: 7497456
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS.
Pan G; Zhou T; Radding W; Saag MS; Mountz JD; McDonald JM
Immunopharmacology; 1998 Aug; 40(2):91-103. PubMed ID: 9826024
[TBL] [Abstract][Full Text] [Related]
11. Reduced CaM/FLIP binding by a single point mutation in c-FLIP(L) modulates Fas-mediated apoptosis and decreases tumorigenesis.
Jing G; Yuan K; Liang Q; Sun Y; Mao X; McDonald JM; Chen Y
Lab Invest; 2012 Jan; 92(1):82-90. PubMed ID: 21912376
[TBL] [Abstract][Full Text] [Related]
12. The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.
Ahn EY; Pan G; Oh JH; Tytler EM; McDonald JM
Am J Pathol; 2003 Nov; 163(5):2053-63. PubMed ID: 14578204
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
[TBL] [Abstract][Full Text] [Related]
14. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
Nzeako UC; Guicciardi ME; Yoon JH; Bronk SF; Gores GJ
Hepatology; 2002 Mar; 35(3):552-9. PubMed ID: 11870367
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
16. Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.
Fernandez TF; Samal AB; Bedwell GJ; Chen Y; Saad JS
J Biol Chem; 2013 Jul; 288(30):21898-908. PubMed ID: 23760276
[TBL] [Abstract][Full Text] [Related]
17. Expression and antitumor effects of TRAIL in human cholangiocarcinoma.
Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR
Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444
[TBL] [Abstract][Full Text] [Related]
18. Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro.
Hunsawong T; Singsuksawat E; In-chon N; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-in S; Thuwajit P
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1311-20. PubMed ID: 22476540
[TBL] [Abstract][Full Text] [Related]
19. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
[TBL] [Abstract][Full Text] [Related]
20. Role of calmodulin in HIV-potentiated Fas-mediated apoptosis.
Pan Z; Radding W; Zhou T; Hunter E; Mountz J; McDonald JM
Am J Pathol; 1996 Sep; 149(3):903-10. PubMed ID: 8780394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
